Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Goat Anti-Equine IgG(H+L)-BIOT

Cat. No.:
6040-08
Goat Anti-Equine IgG(H+L)-Biotin antibody for use in ELISA, flow cytometry, immunocytochemistry, and western blot assays.
$83.00
Size Price (USD) Quantity
1.0 mg $83.00
More Information
Isotype Goat IgG
Isotype Control Goat IgG-BIOT
Specificity Reacts with the heavy and light chains of equine IgG
Source Pooled antisera from goats hyperimmunized with equine IgG
Cross Adsorption None; may react with immunoglobulins from other species and the light chains of other equine immunoglobulins
Purification Method Affinity chromatography on equine IgG covalently linked to agarose
Conjugate BIOT (Biotin)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Polyclonal
Concentration 0.5 mg/mL
Volume 2.0 mL
Recommended Storage 2-8°C
Applications Quality tested applications for relevant formats include -
ELISA 1-3
FLISA

Other referenced applications for relevant formats include -
Flow Cytometry 4,5
Immunocytochemistry 6
Western Blot 7-10
RRID Number AB_2796118

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Hobo S, Niwa H, Anzai T, Jones JH. Changes in serum antibody levels after vaccination for strangles and after intranasal challenge with Streptococcus equi subsp. equi in horses. J Equine Sci. 2010;21:33-7. (ELISA)
  2. 2. De Keyser K, Oosterlinck M, Raes E, Ducatelle R, Janssens S, Buys N. Early detection of chronic progressive lymphoedema susceptibility in Belgian draught horse stallions by means of ELISA. Commun Agric Appl Biol Sci. 2012;77:183-7. (ELISA)
  3. 3. De Keyser K, Berth M, Christensen N, Willaert S, Janssens S, Ducatelle R, et al. Assessment of plasma anti-elastin antibodies for use as a diagnostic aid for chronic progressive lymphoedema in Belgian Draught Horses. Vet Immunol Immunopathol. 2015;163:16-22. (ELISA)
  4. 4. Colson YL, Li H, Boggs SS, Patrene KD, Johnson PC, Ildstad ST. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J Immunol. 1996;157:2820-9. (FC)
  5. 5. Flynn J, Cox CV, Rizzo S, Foukaneli T, Rice K, Murphy M, et al. Direct binding of antithymoctye globulin to haemopoietic progenitor cells in aplastic anaemia. Br J Haematol. 2003;122:289-97. (FC)
  6. 6. Toscan G, Cadore GC, Pereira RC, Silva GB, Cezar AS, Sangioni LA, et al. Equine neosporosis: occurrence of antibodies against Neospora spp. and association between the serological status of the mares and of their offspring. Pesq Vet Bras. 2010;30:641-5. (ICC)
  7. 7. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem. 1997;272:4367-77. (WB)
  8. 8. Warner S, Hartley CA, Stevenson RA, Ficorilli N, Varrasso A, Studdert MJ, et al. Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding. J Virol. 2001;75:9274-81. (WB)
  9. 9. Campbell JE, Brummel-Ziedins KE, Butenas S, Mann KG. Cellular regulation of blood coagulation: a model for venous stasis. Blood. 2010;116:6082-91. (WB)
  10. 10. Zhang J, Meng W, Wang C, Wu Z, Wu G, Xu Y. Expression, purification and characterization of recombinant plasminogen activator from Gloydius brevicaudus venom in Escherichia coli. Protein Expr Purif. 2013;91:85-90. (WB)
See All References